Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs

HSV-2 vaccine is needed to prevent genital disease, latent infection, and virus transmission. A replication-deficient mutant virus (dl5-29) has demonstrated promising efficacy in animal models of genital herpes. However, the immunogenicity, protective efficacy, and non-replicative status of the high...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard, Marie-Clotilde, Barban, Véronique, Pradezynski, Fabrine, de Montfort, Aymeric, Ryall, Robert, Caillet, Catherine, Londono-Hayes, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383384/
https://www.ncbi.nlm.nih.gov/pubmed/25837802
http://dx.doi.org/10.1371/journal.pone.0121518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383384/
https://www.ncbi.nlm.nih.gov/pubmed/25837802
http://dx.doi.org/10.1371/journal.pone.0121518

Ejemplares similares